Padagis®, a Michigan-based leader in generic pharmaceuticals, announced today that the State of Michigan has added its over-the-counter (OTC) Naloxone HCl Nasal Spray 4 mg to the state's distribution ...

Lupin launches Ipratropium Bromide Nasal Solution in the US market; eyes expanding complex generics pipeline to over 200 ...

As respiratory illnesses like COVID-19, influenza, and Mycoplasma pneumonia continue to spread, the need for safe, ...

Lupin launches Ipratropium Bromide nasal spray in US, bioequivalent to Atrovent. The product addresses rhinitis and targets a $63 million market opportunity.

A psychedelic nasal spray requiring a much shorter period of clinical supervision has shown promise against ...

Mumbai: Global pharma major Lupin Limited has launched Ipratropium Bromide Nasal Solution (Nasal Spray), 0.03% and 0.06%, in ...

Using LUCA's proprietary lipid nanocoating technology, the nasal spray demonstrated 99.7% antiviral efficacy within one minute in an in vitro third-party COVID-19 lab study overseas.

Rhode Island colleges will be required to stock the opioid overdose reversal medication naloxone, known by the brand name ...

BPL-003 showed “robust” efficacy data in treatment-resistant depression, according to analysts from Jefferies, who noted that ...

Lupin has announced the launch of Ipratropium Bromide Nasal Solution (nasal spray) in two strengths in the United States.

According to SNS Insider, the global Nasal Spray Market was valued at USD 29.92 billion in 2024 and is projected to reach USD 59.41 billion by 2032, growing at a CAGR of 8.97% during the forecast ...